Clinical trials for Primary pulmonary tuberculosis
23 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT07484490Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in TuberculosisRiphah International University · PI: Nayab shahid, MS-PT
- RECRUITINGPhase 3NCT07209761A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary TuberculosisOtsuka Pharmaceutical Development & Commercialization, Inc. · PI: Simbarashe G Takuva, MD, MSc.
- RECRUITINGPhase 2NCT07170800A Phase 2b Clinical Study of JDB0131 Benzenesulfonate TabletsWestVac Biopharma Co., Ltd.
- RECRUITINGPhase 2NCT06192160Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisNational Institute of Allergy and Infectious Diseases (NIAID) · PI: Radojka Savic, PharmD, PhD
- RECRUITINGPhase 2NCT06748937A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With EthionamideTASK Applied Science · PI: Gifty Okyere-Manu, MBChB
- ACTIVE NOT RECRUITINGN/ANCT07186478I-FALMIN Albumin Supplement for Patients With Pulmonary TuberculosisHasanuddin University
- ACTIVE NOT RECRUITINGPhase 3NCT06649721Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese CohortHuashan Hospital
- RECRUITINGPhase 4NCT06476210The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)Beijing Chest Hospital · PI: Yuhong Liu, Ph.D
- RECRUITINGPhase 2NCT06114628Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBUniversity College, London
- RECRUITINGPhase 2NCT06199921ATORvastatin in Pulmonary TUBerculosisObafemi Awolowo University Teaching Hospital · PI: Olanisun O Adewole, MD
- RECRUITINGPhase 3NCT06727864Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, TrialKaohsiung Veterans General Hospital. · PI: Susan Shin-Jung Lee, MD, PhD
- ACTIVE NOT RECRUITINGPhase 3NCT06081361Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline CohortBeijing Chest Hospital
- RECRUITINGN/ANCT06127641Rehabilitation of People With Post-tuberculosis Lung DiseaseCentro Universitário Augusto Motta
- ACTIVE NOT RECRUITINGPhase 2NCT06058299Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary TuberculosisGlobal Alliance for TB Drug Development · PI: Morounfolu Olugbosi, MD
- RECRUITINGPhase 4NCT06403943Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary TuberculosisBeijing Chest Hospital · PI: WENJUAN NIE, DR
- ACTIVE NOT RECRUITINGNCT05571735Immunogenicity of COVID-19 Vaccines in Tuberculosis PatientsUniversity of Oxford · PI: François Nosten, Professor
- RECRUITINGPhase 2NCT05807399PanACEA - STEP2C -01Michael Hoelscher · PI: Michael Hoelscher, Prof Dr.
- ACTIVE NOT RECRUITINGPhase 2NCT05007821Linezolid Dosing Strategies in Drug-Resistant TBNational Institute of Allergy and Infectious Diseases (NIAID) · PI: Constance A. Benson
- RECRUITINGNCT06706596A Systemic Screening for TB Disease in High-risk Groups in BarcelonaFundació Institut Germans Trias i Pujol · PI: Cristina Vilaplana, MD, PhD
- ACTIVE NOT RECRUITINGNCT05542511Host Blood RNA Signatures for Diagnosis of TBUniversity of Stellenbosch · PI: Anna Okunola, PhD
- RECRUITINGNCT05756582Prevalence of Latent Tuberculosis Infection in Health-care Workers and StudentsEleonora Nucera · PI: Angela Rizzi, MD, PhD
- RECRUITINGPhase 3NCT04260477Novel Triple-dose Tuberculosis Retreatment RegimenInstitute of Tropical Medicine, Belgium · PI: Sani Kadri
- ACTIVE NOT RECRUITINGN/ANCT03851159Nyaditum Resae® as a Co-adjuvant During Treatment for Active Pulmonary Tuberculosis and Its Impact on the Gut MicrobiotaUniversity of Stellenbosch · PI: Grant Theron, PHD